These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32958145)

  • 1. Expression of Arginine Vasopressin Type 2 Receptor in Canine Mammary Tumours: Preliminary Results.
    Benavente MA; Bianchi CP; Aba MA
    J Comp Pathol; 2020 Aug; 179():36-40. PubMed ID: 32958145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Oxytocin Receptors in Canine Mammary Tumours.
    Benavente MA; Bianchi CP; Aba MA
    J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
    Mainenti M; Rasotto R; Carnier P; Zappulli V
    Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
    Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
    Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
    Ozmen O
    Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
    Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
    J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
    Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
    Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.
    Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH
    J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours.
    Geraldes M; Gärtner F; Schmitt F
    Vet Rec; 2000 Apr; 146(14):403-6. PubMed ID: 10791469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
    Reis AL; Carvalheira J; Schmitt FC; Gärtner F
    Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
    Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
    Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential canine mammary tumour cell biomarkers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two-dimensional electrophoresis-based mass spectrometry.
    Fhaikrue I; Srisawat W; Nambooppha B; Pringproa K; Thongtharb A; Prachasilchai W; Sthitmatee N
    Vet Comp Oncol; 2020 Dec; 18(4):787-795. PubMed ID: 32421920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors in canine mammary gland tumours.
    Sobczak-Filipiak M; Malicka E
    Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
    Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
    Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.